OR WAIT null SECS
September 14, 2020
The temporary guidance discusses the resumption of normal manufacturing during the COVID-19 pandemic.
September 13, 2020
Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.
September 11, 2020
In an opinion article, FDA leaders commit to applying “the best science” to approval decisions.
September 09, 2020
PRAC has recommended the marketing authorization of ulipristal acetate for the treatment of uterine fibroids be revoked.
ECCRT and IDDI have established a partnership for the continuous development of IDDI global team members.
Imfinzi has been granted approval in the EU for the treatment of adults with extensive-stage small cell lung cancer.
CPhI has released the agenda for its forthcoming two-week virtual event, CPhI Festival of Pharma.
September 08, 2020
As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.
Industry leaders insist they will maintain high standards for clinical trials and regulatory submissions for new vaccines and therapeutics to combat COVID-19.
September 03, 2020
BIO leaders urge biopharmaceutical companies to apply scientific principles in seeking drug and vaccine approvals.